Neuroscience
Parkinson's Disease
100%
Substantia nigra
31%
Oxidopamine
29%
Reserpine
26%
Pars reticulata
25%
L-DOPA
25%
Basal Ganglia
21%
Neuroprotective Agent
20%
Neuroprotection
19%
Globus pallidus
18%
In Vivo
17%
Metabotropic Glutamate Receptor
17%
Brain
16%
Striatum
13%
Tyrosine Hydroxylase
12%
Receptor Agonists
11%
4 Aminobutyric Acid B Receptor
11%
Riluzole
11%
Dopaminergic Neuron
10%
Dopaminergic
10%
Receptor Agonist
10%
Dopamine
9%
Neuron
8%
Nicotinic Acetylcholine Receptor
7%
Treatment of Parkinson's Disease
7%
Tetrahydropyridine
6%
Nigrostriatal Pathway
6%
Heteroreceptor
6%
Suppression
6%
Forebrain
6%
Antibodies
5%
Zolpidem
5%
Treatment of Pain
5%
Thalamus
5%
Metabotropic Glutamate Receptor 4
5%
Metabotropic Glutamate Receptor 1
5%
Periaqueductal Gray
5%
Spinal Cord
5%
4 Amino 2 oxabicyclo[3.1.0]hexane 4,6 Dicarboxylic Acid
5%
Isoetarine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Animal
18%
Rodent
15%
Rat Model
11%
Metabotropic Receptor 4
11%
Callitrichinae
11%
Positive Allosteric Modulator
7%
Neuroprotection
7%
Growth Factor
6%
Nicotine
5%
Rivanicline
5%
Monoamine Oxidase Inhibitor
5%
Bungarotoxin Receptor
5%
Receptor Agonist
5%
2 (2,3 Dicarboxycyclopropyl)glycine
5%
Clinical Trial
5%